Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.
Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL.
Edwards BJ, et al. Among authors: mehta j.
Lancet Oncol. 2008 Dec;9(12):1166-72. doi: 10.1016/S1470-2045(08)70305-X.
Lancet Oncol. 2008.
PMID: 19038763
Review.